Mostrando 10 resultados de: 127
Filtros aplicados
Publisher
Journal of Alzheimer's Disease(7)
Current Pharmaceutical Design(4)
Neuropharmacology(4)
European Journal of Pharmacology(3)
Journal of Nanobiotechnology(3)
Área temáticas
Enfermedades(83)
Fisiología humana(38)
Medicina y salud(18)
Bioquímica(16)
Fisiología y materias afines(12)
Objetivos de Desarrollo Sostenible
ODS 3: Salud y bienestar(120)
ODS 10: Reducción de las desigualdades(92)
ODS 9: Industria, innovación e infraestructura(72)
ODS 12: Producción y consumo responsables(36)
ODS 2: Hambre cero(16)
Origen
scopus(127)
(±)-huprine Y, (-)-huperzine A and tacrine do not show neuroprotective properties in an apoptotic model of neuronal cytoskeletal alteration
ArticleAbstract: Acetylcholinesterase inhibitors (AChEI) are among the drugs most widely used in the treatment of AlzPalabras claves:acetylcholinesterase inhibitors, Cerebellar granule cells, colchicine, neuronal death, RATAutores:Antoni Camins, Camps P., Canudas A.M., Jiménez A., Jordá E.G., Muñoz-Torrero D., Pallás M., Rimbau V., Verdaguer E.Fuentes:scopus3,4-Methylenedioxymethamphetamine enhances kainic acid convulsive susceptibility
ArticleAbstract: Kainic acid (KA) causes seizures and neuronal loss in the hippocampus. The present study investigatePalabras claves:Calbindin, Calretinin, Kainic acid, MDMA, Parvalbumin, seizuresAutores:Abad S., Antoni Camins, Auladell C., Camarasa J., Escubedo E., Junyent F., Pallás M., Pubill D.Fuentes:scopus3-Amino thioacridone, a selective cyclin-dependent kinase 4 inhibitor, attenuates kainic acid-induced apoptosis in neurons
ArticleAbstract: The mechanisms underlying selective neuronal cell death in kainic acid-mediated neurodegeneration arPalabras claves:cell cycle, Cyclin-dependent kinases, Excitotoxicity, Neurodegenerative illnessAutores:Antoni Camins, Camarasa J., Canudas A.M., Escubedo E., Jiménez A., Jordá E.G., Pallás M., Pubill D., Rimbau V., Sureda F.X., Verdaguer E.Fuentes:scopusA molecular study of pathways involved in the inhibition of cell proliferation in neuroblastoma B65 cells by the GSK-3 inhibitors lithium and SB-415286
ArticleAbstract: Pharmacological GSK-3 inhibitors are potential drugs for the treatment of neurodegenerative diseasesPalabras claves:apoptosis, B65 cells, Cdc2, GSK3, Lithium, SB-415286Autores:Antoni Camins, Esparza J.L., Folch J., Jordan J., Pallás M., Pizarro J.G.Fuentes:scopusA new aspect of the antiproliferative action of peripheral-type benzodiazepine receptor ligands
ArticleAbstract: Ro 5-4864 (4-chlorodiazepam), PK 11195 (1-(2-chlorophenyl)-1,3-dihydro-1-methyl-propyl)isoquinolinePalabras claves:(Chinese hamster), Benzodiazepine, cell proliferation, LungAutores:Antoni Camins, Camarasa J., Diez-Fernandez C., Escubedo E., Pujadas E.Fuentes:scopusA novel rhein-huprine hybrid ameliorates disease-modifying properties in preclinical mice model of Alzheimer’s disease exacerbated with high fat diet
ArticleAbstract: Background: Alzheimer’s disease (AD) is characterized by a polyetiological origin. Despite the globaPalabras claves:Alzheimer’s disease, BACE1, BDNF, cognitive decline, dendritic spines, high-fat diet, neuroinflammation, Rhein-huprine hybrid, Tau, TLR4Autores:Antoni Camins, Auladell C., Bulló M., Cano A., Espinosa-Jimenez T., Ettcheto M., Folch J., Muñoz-Torrero D., Olloquequi J., Parcerisas A., Pont C., Sanchez-Lopez E., Verdaguer E.Fuentes:scopusADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker
ReviewAbstract: Alzheimer's disease (AD) represents a global burden in the economics of healthcare systems. Amyloid-Palabras claves:ADAM10, Alzheimer's disease, Natural compounds, Pharmaceutical, α-SecretaseAutores:Antoni Camins, Busquets O., Cano A., Cominetti M.R., Di Luca M., Endres K., Ettcheto M., Manzine P.R., Marcello E., Olloquequi J., Pelucchi S.Fuentes:scopusCharacterization and differentiation of peripheral-type benzodiazepine receptors in rat and human prostate
ArticleAbstract: We have characterized the presence of peripheral-type benzodiazepine receptor in rat and human prostPalabras claves:Autores:Antoni Camins, Camarasa J., Escubedo E., Pubill D., Sureda F.X.Fuentes:scopusCharacterization of [<sup>3</sup>H]Ro 5‐4864 Binding Sites in Rat Vas Deferens
ArticleAbstract: Abstract: The presence of benzodiazepine binding sites in rat vas deferens was detected using [3H]RoPalabras claves:Binding sites, Mitochondria, Peripheral‐type benzodiazepine receptor, RAT, Ro 5‐4864, Vas deferensAutores:Antoni Camins, Camarasa J., Escubedo E., Talaveron C.Fuentes:scopusCharacterization of [<sup>3</sup>H]nisoxetine binding in rat vas deferens membranes: Modulation by sigma and PCP ligands
ArticleAbstract: Sigma (σ) and phencyclidine (PCP) receptor ligands, apart from their main effects on σ receptors andPalabras claves:Noradrenaline transporter, PCP ligands, Sigma ligands, Vas deferens, [ H]nisoxetine 3Autores:Antoni Camins, Camarasa J., Escubedo E., Gasulla D., Pallás M., Pubill D., Sureda F.X.Fuentes:scopus